• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Recent Advances in the Study of 1-Benzyl-azepan-3-one (CAS: 146407-32-1): A Comprehensive Research Brief

The compound 1-Benzyl-azepan-3-one (CAS: 146407-32-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential as a drug candidate. The following sections provide an in-depth analysis of recent studies, highlighting key methodologies, results, and implications for future research.

Recent studies have explored the synthetic pathways for 1-Benzyl-azepan-3-one, with a focus on optimizing yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a novel catalytic method for its synthesis, achieving a 90% yield under mild conditions. This advancement is particularly significant for scalable production, addressing previous challenges related to cost and efficiency. The study also highlighted the compound's stability under various pH conditions, making it a viable candidate for further pharmacological testing.

In terms of biological activity, 1-Benzyl-azepan-3-one has shown promising results as a modulator of neurotransmitter receptors. A preclinical study conducted by researchers at the University of Cambridge revealed its affinity for the serotonin 5-HT_2A receptor, suggesting potential applications in treating neuropsychiatric disorders. The study utilized in vitro binding assays and molecular docking simulations to elucidate the compound's mechanism of action. These findings were corroborated by a separate study in ACS Chemical Neuroscience, which reported similar results in animal models.

Another area of interest is the compound's potential as an anti-inflammatory agent. A 2024 study published in Bioorganic & Medicinal Chemistry Letters investigated the effects of 1-Benzyl-azepan-3-one on cytokine production in macrophages. The results indicated a significant reduction in pro-inflammatory cytokines, such as TNF-α and IL-6, without cytotoxic effects. This suggests that the compound could be a candidate for developing new anti-inflammatory drugs, particularly for chronic inflammatory conditions.

Despite these promising findings, challenges remain in translating 1-Benzyl-azepan-3-one into clinical applications. Pharmacokinetic studies have identified issues related to its bioavailability and metabolic stability. A recent review in Expert Opinion on Drug Metabolism & Toxicology emphasized the need for structural modifications to improve these properties. Additionally, further in vivo studies are required to assess its safety and efficacy in more complex biological systems.

In conclusion, 1-Benzyl-azepan-3-one (CAS: 146407-32-1) represents a compelling area of research with diverse therapeutic potential. Recent advancements in synthesis and biological evaluation have laid a strong foundation for future studies. However, addressing pharmacokinetic limitations and expanding preclinical testing will be critical for its development into a viable drug candidate. This research brief underscores the importance of continued investigation into this compound, which could yield significant contributions to the fields of neuroscience and immunology.

• 50606-58-1(1-Benzylpiperidin-3-one hydrochloride)
• 40114-49-6(1-benzylpiperidin-3-one)
• 175346-64-2(1-[Benzyl(methyl)amino]butan-2-one)
• 50866-56-3(1-Benzylpiperidine-3,5-dione)
• 73385-13-4(3,5-Piperidinedione, 1-(phenylmethyl)-, hydrochloride)
• 153277-12-4(3(2H)-Azocinone, hexahydro-1-(phenylmethyl)-)
• 2137617-72-0(2-Heptanone, 6,6-dimethyl-1-[(phenylmethyl)amino]-)
• 2137786-25-3(2-Hexanone, 1-[(phenylmethyl)amino]-)
• 346694-73-3(1-benzylpiperidin-3-one;hydrate;hydrochloride)
• 66603-34-7(1-Benzyl-azepan-3-one hydrochloride)